SEC Filing Details
Document Details
Form
Filing Date
Jun 10, 2024
Document Date
Jun 6, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Aclaris Therapeutics, Inc.
Issuer
Aclaris Therapeutics, Inc.
Filer
Molineaux Christopher P.